Table 7.
Cumulative cost analysis of all blood products (n = 55 patients with CPB time ≥ 115 min)
| Variables | CONTROL | ROTEM® |
|---|---|---|
| Number | 26 (47%) | 29 (53%) |
| intraoperative | ||
| RBCs (unit: 70 €) | 2520 | 2240 |
| FFPs (unit: 51 €) | 1530 | 1020 |
| Platelet concentrates (unit: 500 €) | 4000 | 1500 |
| Fibrinogen (1 g: 287.5 €) | 1438 | 1150 |
| PPSB (500 IU: 120 €) | 1200 | 1080 |
| AT3 (1000 IU: 70 €) | 350 | 245 |
| Aprotinin (2.5 Mio IU 123.75 €) | 668 | 2574 |
| Tranexamic acid (500 mg: 7.63 €) | 595 | 732 |
| Cumulative costs [€] | 12,301 | 10,541 |
| ICU (after randomization) | ||
| RBCs (unit: 70 €) | 12,460 | 7140 |
| FFPs (unit: 51 €) | 5304 | 2397 |
| Platelet concentrates (unit: 500 €) | 13,000 | 5000 |
| Fibrinogen (1 g: 287.5 €) | 1150 | 6900 |
| PPSB (500 IU: 120 €) | 0 | 0 |
| AT3 (1000 IU: 70 €) | 70 | 0 |
| Aprotinin (2.5 Mio IU: 123.75 €) | 495 | 0 |
| Tranexamic acid (500 mg: 7.63 €) | 31 | 31 |
| Cumulative costs [€] | 32,510 | 21,468 |
| Overall cumulative costs [€] | 44,811 | 32,009 |
| Costs per patient [€] | 1723.5 | 1103.8 |
| Costs savings per patient [€] | – | 619.8 |